Burden of Pulmonary Rifampicin-Resistant Tuberculosis in Kajiado, Kenya: An Observational Study

Burden of Pulmonary Rifampicin-Resistant Tuberculosis in Kajiado, Kenya: An Observational Study

Background: Rifampicin resistance (RR) is a major challenge in the clinical management of tuberculosis (TB), but data on its prevalence are still sparse in many countries. Our study aimed at estimating the prevalence of RR-TB in Kajiado County, Kenya. Secondary objectives were to estimate the incide...

Full description

Bibliographic Details
Main Authors:	Paolo Cattaneo, Caleb Mike Mulongo, Gianfranco Morino, Maria Vittoria De Vita, Gabriele Paone, Simone Scarlata, Salome Kinyita, Hillary Odhiambo, Cristina Mazzi, Federico Gobbi, Dora Buonfrate
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Microorganisms
Subjects:	tuberculosis rifampicin resistance active-case finding Kenya Kajiado HIV coinfection
Online Access:	https://www.mdpi.com/2076-2607/11/5/1280

Similar Items

Finding the missing many: improving Tuberculosis care in Kajiado county through active case finding and community approaches
by: Gianfranco Morino, et al.
Published: (2024-01-01)

Factors affecting provision of female family planning commodities in public health facilities in Kajiado county, Kenya
by: Fredrick Githinji, et al.
Published: (2022-12-01)

Seroprevalence and spatial distribution of livestock brucellosis using three serological tests in Kajiado County, Kenya
by: Mahacla Omung'ala Odongo, et al.
Published: (2023-12-01)

LAND REFORM IN THE CONTEXT OF DEVOLUTION: LESSONS FROM KAJIADO COUNTY, KENYA
by: Everlyne Komba, et al.
Published: (2018-09-01)

LAND REFORM IN THE CONTEXT OF DEVOLUTION: LESSONS FROM KAJIADO COUNTY, KENYA
by: Everlyne Komba, et al.
Published: (2018-09-01)

Occupational safety and health status of medical laboratories in Kajiado County, Kenya
by: Fridah Ntinyari Tait, et al.
Published: (2018-01-01)

Prevalence of subclinical mastitis, associated risk factors and antimicrobial susceptibility pattern of bacteria isolated from milk of dairy cattle in Kajiado Central sub‐county, Kenya
by: Lynda Michira, et al.
Published: (2023-11-01)

Rifampicin-Induced Thrombocytopenia: A Rare Complication
by: Ravi Dosi, et al.
Published: (2019-01-01)

Rifampicin-induced acute thrombocytopenia
by: Banu Rekha V, et al.
Published: (2005-01-01)

A case of severe thrombocytopenia after the first exposure to rifampicin
by: Chinatsu Nakane, et al.
Published: (2023-01-01)

The efficacy and tolerability of rifampicin in Burmese patients with lepromatous leprosy
by: TIN SHWE, et al.
Published: (1978-06-01)

Tuberculosis case finding using population-based disease surveillance platforms in urban and rural Kenya
by: Godfrey Bigogo, et al.
Published: (2018-06-01)

Development of Pseudomembranous Colitis Four Months after Initiation of Rifampicin
by: Jeong Moon Choi, et al.
Published: (2011-01-01)

Molecular Characterization of Rifampicin Associated Mutation in Mycobacterium tuberculosis Isolates
by: Ali Tahir, et al.
Published: (2021-06-01)

Relative Bioavailability of Rifampicin in Four Chinese Fixed-dose Combinations Compared with Rifampicin in Free Combinations
by: Hui Zhu, et al.
Published: (2015-01-01)

Rifampicin induced adrenal crisis in an uncommon setting
by: Animesh Ray, et al.
Published: (2013-01-01)

Influence of isoniazid on the metabolism of rifampicin on rat hepatocytes
by: Fasich Fasich, et al.
Published: (2000-06-01)

Evaluation of the genexpert Mycobacterium tuberculosis/Rifampicin assay for early detection of extrapulmonary tuberculosis and rifampicin resistance in aligarh region of Northern India
by: M D Ahsan Imam, et al.
Published: (2023-01-01)

Role of Ascorbic Acid in Portal Inflammation Induced by Rifampicin
by: Iram Tassaduq
Published: (2012-06-01)

MazEF-rifampicin interaction suggests a mechanism for rifampicin induced inhibition of persisters
by: Cyrus Alexander, et al.
Published: (2020-10-01)

Poor response to tuberculosis treatment with regimens without rifampicin in immunosuppressed AIDS patients
by: M.M. O'Donnel, et al.

Ofloxacin plus Rifampicin versus Doxycycline plus Rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]
by: Kayas Derya, et al.
Published: (2004-06-01)

Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm
by: Anna Gidari, et al.
Published: (2020-08-01)

Time to be vigilant in contacts of leprosy for possible single-dose rifampicin
by: Pugazhenthan Thangaraju, MD, et al.
Published: (2022-11-01)

Enhancing antimycobacterial activity of isoniazid and rifampicin incorporated norbornene nanoparticles
by: Kalaiselvi Kumarasingam, et al.
Published: (2018-01-01)

Malnutrition, morbidity and infection in the informal settlements of Nairobi, Kenya: an epidemiological study
by: Maria Vittoria De Vita, et al.
Published: (2019-01-01)

Effect of rifampicin on the kidney of albino rats
by: DE Peters, et al.
Published: (2013-07-01)

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
by: Carolina Arana Stanis Schmaltz, et al.
Published: (2019-02-01)

Determinants of pastoral and agro-pastoral households’ participation in fodder production in Makueni and Kajiado Counties, Kenya
by: Erick Ouma Omollo, et al.
Published: (2018-03-01)

Genetic Screen Reveals the Role of Purine Metabolism in Staphylococcus aureus Persistence to Rifampicin
by: Rebecca Yee, et al.
Published: (2015-12-01)

Molecular quantification of Rifampicin-resistance in Mycobacterium tuberculosis
by: Abdulameer Abuallh Al-Mussawi, et al.
Published: (2017-07-01)

The relevancy of controlled nanocrystallization on rifampicin characteristics and cytotoxicity
by: Mohyeldin SM, et al.
Published: (2016-05-01)

Development and Evaluation of Rifampicin Loaded Alginate–Gelatin Biocomposite Microfibers
by: Ameya Sharma, et al.
Published: (2021-05-01)

Selenium as a therapeutic adjuvant for isoniazid/rifampicin-induced hepatotoxicity
by: Elias Adikwu, et al.
Published: (2020-01-01)

Four months of rifampicin monotherapy for latent tuberculosis infection in children
by: Chi Eun Oh, et al.
Published: (2022-05-01)

Pharmacokinetic interactions between rifampicin and efavirenz in HIV-TB coinfections
by: Yenny
Published: (2009-12-01)

Pharmacokinetic interactions between rifampicin and efavirenz in HIV-TB coinfections
by: Yenny Yenny
Published: (2016-02-01)

Rifampicin-Induced Nephrotoxicity in a Tuberculosis Patient: Treatment Dilemma?
by: Antonio Grilo Novais, et al.
Published: (2021-10-01)

Evaluation of the resistance of Mycobacterium tuberculosis to rifampicin at the regional hospital center of Maradi, Niger Republic
by: Ousmane Abdoulaye, et al.
Published: (2022-01-01)

Rifampicin-induced interstitial nephritis: A case report and a short review of the literature
by: Ghouse Ahmed Khan, et al.
Published: (2016-07-01)